Alice Goodman

Longer Sleep Duration per Night Associated with Increased Risk of Stroke in Older Women
01/17/2011
Research suggests that the risk of stroke is elevated in women who have more—not less—sleep. Women who slept ≥10 hours per night had a 63% increased risk of stroke compared with those who slept <7 hours per night in a substudy of the...
Research suggests that the risk of stroke is elevated in women who have more—not less—sleep. Women who slept ≥10 hours per night had a 63% increased risk of stroke compared with those who slept <7 hours per night in a substudy of the...
Research suggests that the risk...
01/17/2011
First Report Managed Care
Feature
Drug-Eluting Stents as Safe as Bare-Metal Stents and More Effective in Large Coronary Arteries
01/17/2011
Chicago—Drug-eluting stents (sirolimus-eluting and everolimus-eluting) were found as safe as a baremetal stent in large arteries of patients with coronary heart disease in the BASKET-PROVE (Basel Stent Kosten-Effektivitäts Trial Prospective...
Chicago—Drug-eluting stents (sirolimus-eluting and everolimus-eluting) were found as safe as a baremetal stent in large arteries of patients with coronary heart disease in the BASKET-PROVE (Basel Stent Kosten-Effektivitäts Trial Prospective...
Chicago—Drug-eluting stents...
01/17/2011
First Report Managed Care
Department
Ibuprofen/Famotidine versus Ibuprofen Alone in Chronic NSAID Users
02/15/2011
A combination tablet dubbed HZT-501 reduces gastrointestinal ulcers overall in chronic nonsteroidal antiinflammatory drug users.
A combination tablet dubbed HZT-501 reduces gastrointestinal ulcers overall in chronic nonsteroidal antiinflammatory drug users.
A combination tablet dubbed...
02/15/2011
First Report Managed Care
Feature
Acetylcysteine in Patients Undergoing Cardiac Imaging
02/15/2011
Chicago—A drug intended to prevent contrast-induced kidney damage in patients undergoing cardiac imaging failed to work in a large, randomized trial. Acetylcysteine failed to reduce the short-term risks of contrast-induced nephropathy or any...
Chicago—A drug intended to prevent contrast-induced kidney damage in patients undergoing cardiac imaging failed to work in a large, randomized trial. Acetylcysteine failed to reduce the short-term risks of contrast-induced nephropathy or any...
Chicago—A drug intended to...
02/15/2011
First Report Managed Care
Department
Uveitis: Dangerous and Costly
02/15/2011
Atlanta—Uveitis (eye inflammation) poses a substantial economic burden, and associated costs increase with the number of uveitis-related medical visits. In patients who develop uveitis-related blindness, direct and indirect costs are...
Atlanta—Uveitis (eye inflammation) poses a substantial economic burden, and associated costs increase with the number of uveitis-related medical visits. In patients who develop uveitis-related blindness, direct and indirect costs are...
Atlanta—Uveitis (eye...
02/15/2011
First Report Managed Care
Feature
One in 5 Young Adults with Chronic Lower Back Pain Actually Had Spondyloarthritis
02/15/2011
As many as 20% of patients treated by PCPs for chronic lower back pain may actually have spondyloarthritis and should be referred to a rheumatologist for diagnosis and treatment, according to a study presented at the ACR meeting.
As many as 20% of patients treated by PCPs for chronic lower back pain may actually have spondyloarthritis and should be referred to a rheumatologist for diagnosis and treatment, according to a study presented at the ACR meeting.
As many as 20% of patients...
02/15/2011
First Report Managed Care
Department
Rilonacept: A Novel Approach to Gout
02/15/2011
Ongoing treatment with rilonacept reduced gout flares during urate-lowering therapy, according to a phase 3 study reported at the ACR meeting.
Ongoing treatment with rilonacept reduced gout flares during urate-lowering therapy, according to a phase 3 study reported at the ACR meeting.
Ongoing treatment with...
02/15/2011
First Report Managed Care
Conference Insider
Prescribing for Rheumatoid Arthritis Leaves Much to Be Desired
02/15/2011
Many patients with rheumatoid arthritis (RA) are not being treated appropriately, according to 2 studies presented at the ACR meeting. 
Many patients with rheumatoid arthritis (RA) are not being treated appropriately, according to 2 studies presented at the ACR meeting. 
Many patients with rheumatoid...
02/15/2011
First Report Managed Care
Feature
Novel Oral Anticoagulant May Be Alternative to Warfarin in AF
05/05/2010
Atlanta—Betrixaban, an investigational oral factor Xa inhibitor, was safe and well tolerated, with a similar or lower risk of major bleeding compared with warfarin in patients with nonvalvular atrial fibrillation (AF) or atrial flutter who...
Atlanta—Betrixaban, an investigational oral factor Xa inhibitor, was safe and well tolerated, with a similar or lower risk of major bleeding compared with warfarin in patients with nonvalvular atrial fibrillation (AF) or atrial flutter who...
Atlanta—Betrixaban, an...
05/05/2010
First Report Managed Care
Conference Insider
Excessive Daytime Sleepiness Contributes to Medication Nonadherence
01/17/2011
Community-dwelling adults with heart failure (HF) often forget to take their HF medications due to excessive daytime sleepiness, according to a study reported at a poster session during the AHA meeting. 
Community-dwelling adults with heart failure (HF) often forget to take their HF medications due to excessive daytime sleepiness, according to a study reported at a poster session during the AHA meeting. 
Community-dwelling adults with...
01/17/2011
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use